In addition, according to the analysis of the second phase clinical results published by Sinopharm Holdings and Kexing Company respectively, the titer of neutralizing antibody of Sinopharm is better than that of Kexing Company. Now, COVID-19 vaccines of Kexing and Sinopharm can be registered, and the domestic vaccines are similar, but Kexing used to mainly target foreign countries, so the effect is the same.
Sinopharm Holdings China Bio's two inactivated COVID-19 vaccines.
According to public reports, the specifications of two COVID-19 inactivated vaccines of Sinopharm China Bio and another COVID-19 inactivated vaccine developed by Beijing Kexing are both 0.5ml, but the usage and dosage are slightly different.
Among them, China Institute of Biology has 2 ~ 3 doses of vaccine basic immunization, and the interval between/kloc-0 and the second dose is 2 ~ 4 weeks, and the interval between the second dose and the third dose is 4 weeks; 2 doses of basic immunization in China Institute of Biology, with an interval of 2-4 weeks. When the nemesis vaccine is used for emergency vaccination, the basic immunization program is 2 doses, with an interval of 2 weeks. When used for routine vaccination, the basic immunization program is 2 doses, with an interval of 1 month.